BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34156310)

  • 1. Single-arm oncology trials and the nature of external controls arms.
    Hashmi M; Rassen J; Schneeweiss S
    J Comp Eff Res; 2021 Aug; 10(12):1052-1066. PubMed ID: 34156310
    [No Abstract]   [Full Text] [Related]  

  • 2. A Comparison of Seven Oncology External Control Arm Case Studies: Critiques From Regulatory and Health Technology Assessment Agencies.
    Jaksa A; Louder A; Maksymiuk C; Vondeling GT; Martin L; Gatto N; Richards E; Yver A; Rosenlund M
    Value Health; 2022 Dec; 25(12):1967-1976. PubMed ID: 35760714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an External Control Arm Using Electronic Health Record-Based Real-World Data to Evaluate the Efficacy of COVID-19 Treatment.
    Jeon JY; Kim MJ; Im YJ; Kim EY; Kim JS; Kwon KT; Hwang JH; Kim JS; Kim MG
    Clin Pharmacol Ther; 2023 Jun; 113(6):1274-1283. PubMed ID: 36861352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations.
    Silva P; Janjan N; Ramos KS; Udeani G; Zhong L; Ory MG; Smith ML
    Front Med (Lausanne); 2023; 10():1198088. PubMed ID: 37484840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer.
    Yin X; Mishra-Kalyan PS; Sridhara R; Stewart MD; Stuart EA; Davi RC
    J Biopharm Stat; 2022 Jan; 32(1):204-218. PubMed ID: 34986069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current perspectives for external control arms in oncology clinical trials: Analysis of EMA approvals 2016-2021.
    Wang X; Dormont F; Lorenzato C; Latouche A; Hernandez R; Rouzier R
    J Cancer Policy; 2023 Mar; 35():100403. PubMed ID: 36646208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Next Horizon of Drug Development: External Control Arms and Innovative Tools to Enrich Clinical Trial Data.
    Zou KH; Vigna C; Talwai A; Jain R; Galaznik A; Berger ML; Li JZ
    Ther Innov Regul Sci; 2024 May; 58(3):443-455. PubMed ID: 38528279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data extraction from electronic health records (EHRs) for quality measurement of the physical therapy process: comparison between EHR data and survey data.
    Scholte M; van Dulmen SA; Neeleman-Van der Steen CW; van der Wees PJ; Nijhuis-van der Sanden MW; Braspenning J
    BMC Med Inform Decis Mak; 2016 Nov; 16(1):141. PubMed ID: 27825333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Real-World Evidence to Support FDA Approval of Oncology Drugs.
    Feinberg BA; Gajra A; Zettler ME; Phillips TD; Phillips EG; Kish JK
    Value Health; 2020 Oct; 23(10):1358-1365. PubMed ID: 33032780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embodied Conversational Agents in Clinical Psychology: A Scoping Review.
    Provoost S; Lau HM; Ruwaard J; Riper H
    J Med Internet Res; 2017 May; 19(5):e151. PubMed ID: 28487267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition, structure, content, use and impacts of electronic health records: a review of the research literature.
    Häyrinen K; Saranto K; Nykänen P
    Int J Med Inform; 2008 May; 77(5):291-304. PubMed ID: 17951106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Causal Inference for External Comparator Arm Studies.
    Rippin G; Ballarini N; Sanz H; Largent J; Quinten C; Pignatti F
    Drug Saf; 2022 Aug; 45(8):815-837. PubMed ID: 35895225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting.
    Massey PR; Wang R; Prasad V; Bates SE; Fojo T
    Oncologist; 2016 Mar; 21(3):261-8. PubMed ID: 26888691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a health information technology survey to explore the availability of addiction treatment data in the electronic health records: A National Drug Abuse Treatment Clinical Trials Network study.
    Wu LT; Payne EH; Roseman K; Case A; Nelson C; Lindblad R
    J Subst Abuse Treat; 2020 Mar; 112S():56-62. PubMed ID: 32220412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer.
    Griffith SD; Tucker M; Bowser B; Calkins G; Chang CJ; Guardino E; Khozin S; Kraut J; You P; Schrag D; Miksad RA
    Adv Ther; 2019 Aug; 36(8):2122-2136. PubMed ID: 31140124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peak systolic velocity and color aliasing are important in the development of duplex ultrasound criteria for external carotid artery stenosis.
    Kronick MD; Chopra A; Swamy S; Brar V; Jung E; Abraham CZ; Liem TK; Landry GJ; Moneta GL
    J Vasc Surg; 2020 Sep; 72(3):951-957. PubMed ID: 31964570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interoperability of clinical decision-support systems and electronic health records using archetypes: a case study in clinical trial eligibility.
    Marcos M; Maldonado JA; Martínez-Salvador B; Boscá D; Robles M
    J Biomed Inform; 2013 Aug; 46(4):676-89. PubMed ID: 23707417
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.